UK Parliament / Open data

Forensic Science Regulator and Biometrics Strategy Bill

The regulator has been able to introduce codes of practice, but where they have not been followed, she has not been able to enforce them, which is one of the main issues today. As I understand it, the codes of practice are published in co-ordination with the Home Office, so perhaps the Minister can give an update on the outstanding codes that the hon. Gentleman mentions.

The market’s dependence on large or specialised service providers is not an abstract concern. We know that the resulting fragility, which already existed because of a lack of competition in the market, has had damaging effects on people in the criminal justice system. The collapse of key forensic services in 2018 is a case in point. To manage the fall-out from that collapse, police forces contracted other commercial providers to take on the resulting workload, creating system-wide capacity constraints. The appalling consequences that the Forensic Sciences Regulator laid out show that some cases, where forensic science may have provided valuable information or evidence, could not be processed. In addition, there was evidence of an increased error rate during this period, as well as an unsustainable strain on staff working overtime.

I am sure that all hon. Members agree that that is an unacceptable position for part of the criminal justice system to be in and that we should do our best to try to fix it. At the risk of straying a little beyond the immediate scope of the Bill, I urge Ministers to recognise the systemic issues that such cases highlight. Giving the regulator statutory powers will raise standards but cannot by itself mend a broken market. In the medium-term, the only way to get forensics right is through sustained investment in people, processes and skills.

I am sure that other hon. Members will have examples on which to draw, but the way in which violent sexual crimes are prosecuted makes an especially clear case for why statutory powers are so important. Such crimes, which are subject to unique challenges in obtaining convictions, often rely on DNA evidence as the critical element of a prosecution case. It is therefore vital that the possibility of contamination, for example, at sexual assault referral centres, is minimised as far as possible, yet the regulator’s 2016 annual report highlighted instances of DNA swabs being contaminated through unrelated case handling of different victims on the same day. Clearly, that is unacceptable.

Ensuring adherence to the regulator’s quality standards is a basic precaution, as victims and the general public rightly expect. However, the cost of testing to achieve compliance has meant that the commissioners of affected centres are unlikely to co-operate unless the regulator is empowered to require that. That inadequate incentive structure gets to the heart of why the current soft regulatory model is so weak for existing markets. The regulator’s highest aspiration is to create a competitive climate, in which underperforming or corner-cutting suppliers are unable to acquire contracts.

Type
Proceeding contribution
Reference
680 c1250 
Session
2019-21
Chamber / Committee
House of Commons chamber
Back to top